Skip to main content
. Author manuscript; available in PMC: 2008 May 2.
Published in final edited form as: Pediatr Crit Care Med. 2005 Sep;6(5):537–541. doi: 10.1097/01.PCC.0000164638.44600.67

Table 3.

Risk of management strategies designed to reduce elevated intracranial pressure based on whether an intracranial pressure monitor was in place (n = 25)

Intracranial Pressure Monitor
Yes
No. (%)		 No
No. (%)		 RR (95% CI)
Barbiturate coma
 Yes 3 (12.0) 1 (0.9) 4.5 (2.3–8.9)
 No 22 (88.0) 110 (99.1)
Cooling
 Yes 9 (36.0) 1 (0.9) 7.1 (4.3–11.7)
 No 16 (64.0) 110 (99.1)
Hyperventilation
 Yes 9 (36.0) 5 (4.5) 4.9 (2.7–8.9)
 No 16 (64.0) 106 (95.5)
Mannitol
 Yes 18 (72.0) 14 (12.6) 7.8 (3.8–18.2)
 No 7 (28.0) 97 (87.4)
Phenytoin
 Yes 18 (72.0) 39 (35.1) 3.6 (1.6–8.0)
 No 7 (28.0) 72 (64.9)
Steroids
 Yes 2 (8.0) 4 (3.6) 1.9 (0.6–6.2)
 No 23 (92.0) 107 (96.4)

RR, relative risk; CI, confidence interval.